LeMaitre Vascular, Inc. (LMAT) Q3 2023 Earnings Results

Lemaitre Vascular (LMAT) Beats on EPS, Stock Down 1.56%

Lemaitre Vascular's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 1.56%, likely due to the lack of revenue data and no guidance for future performance. Investors may be cautious given the absence of detailed financial outlook and ongoing supply chain issues.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.33	N/A	+6.45%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management conveyed a cautiously optimistic outlook, focusing on product demand and market opportunities. They acknowledged supply chain challenges but remain committed to growth.

Management highlighted ongoing product demand and market expansion efforts.

They noted challenges in supply chain but expressed confidence in long-term growth.

The team emphasized their commitment to innovation and customer satisfaction.

Lemaitre Vascular (LMAT) Beats on EPS, Stock Down 1.56%

Key numbers

Management commentary

LeMaitre Vascular, Inc.

More earnings this week

Lemaitre Vascular (LMAT) Beats on EPS, Stock Down 1.56%

Key numbers

Management commentary